Breaking News
Using diffusion-weighted MRI to visualize brain inflammation in vivo for the first time
Eosinophilic Diseases Often Overlap, Raising Costs
Seizure-related emergency visits dropped in early pandemic period
Argentina reports case of monkeypox; man traveled from Spain
FDA Okays IN.PACT 018 Drug-Coated Balloon for PAD
In long COVID, blood markers are linked to neuropsychiatric ills
Exposure of microbial communities to antibiotics could facilitate the spread of plasmid-encoded genes
Skip to content
  • Health Problems
  • Personal Health
  • Family Health
  • Health News
  • Kids Health
  • Medications
  • Beauty & Balance

FLORESHEALTH

  • Health Problems
  • Personal Health
  • Family Health
  • Health News
  • Kids Health
  • Medications
  • Beauty & Balance

Home ยป approves

FDA Approves Fexinidazole as the First All-Oral Treatment for Sleeping Sickness

July 23, 2021Medications

July 19, 2021 — The US Food and Drug Administration (FDA) has approved fexinidazole as the first all-oral treatment for…

approves, as, FDA, Fexinidazole, T

FDA Approves Sarclisa (isatuximab-irfc) in Combination with Carfilzomib and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

April 7, 2021Medications

PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with…

(isatuximab-irfc), and, approves, Carfilzomib, combination, dexamethasone, FDA, for, in, multiple, myeloma, or, Patients, Refractory, Relapsed, Sarclisa, With

China approves a fourth COVID-19 vaccine for emergency use

March 16, 2021Health News

China has approved a new COVID-19 vaccine for emergency use, one that was developed by the head of its Center…

a, approves, China, COVID-19, Emergency, for, Fourth, Use, Vaccine

FDA Approves Libtayo (cemiplimab-rwlc) as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma

February 10, 2021Medications

TARRYTOWN, N.Y. and PARIS, Feb. 9, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.…

(cemiplimab-rwlc), advanced, approves, as, Basal, Carcinoma, cell, FDA, first, for, immunotherapy, Indicated, Libtayo, Patients, With

FDA Approves Breyanzi

February 9, 2021Medications

FDA Approves Breyanzi (lisocabtagene maraleucel) CAR-T Cell Therapy for Adults with Relapsed or Refractory Large B-cell Lymphoma PRINCETON, N.J.–(BUSINESS WIRE)…

approves, Breyanzi, FDA

FDA Approves Posimir

February 2, 2021Medications

FDA Approves Posimir (bupivacaine) for Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression CUPERTINO, Calif., Feb.…

approves, FDA, Posimir

Egypt approves Chinese Sinopharm COVID-19 vaccine

January 3, 2021Health News

Egypt has approved the use of a COVID-19 vaccine developed by Chinese pharma giant Sinopharm with its rollout to start…

approves, Chinese, COVID-19, Egypt, Sinopharm, Vaccine

US approves Regeneron antibody treatment given to Trump

November 23, 2020Health News

A COVID-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for…

antibody, approves, given, Regeneron, to, Treatment, Trump, US

FDA Approves Palforzia

February 9, 2020Medications

FDA Approves Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] as First Treatment for Peanut Allergy BRISBANE, Calif.–(BUSINESS WIRE)–Jan. 31, 2020– Aimmune…

approves, FDA, Palforzia

FDA Approves Keytruda (pembrolizumab) for the Adjuvant Treatment of Patients with Melanoma with Involvement of Lymph Node(s) Following Complete Resection

February 20, 2019Medications

KENILWORTH, N.J.–(BUSINESS WIRE) February 19, 2019 –Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced…

(pembrolizumab), Adjuvant, approves, Complete, FDA, following, for, Involvement, Keytruda, Lymph, Melanoma, Node(s), of, Patients, Resection, the, Treatment, With

Posts navigation

1 2 Next
Recent Posts
  • Using diffusion-weighted MRI to visualize brain inflammation in vivo for the first time
  • Eosinophilic Diseases Often Overlap, Raising Costs
  • Seizure-related emergency visits dropped in early pandemic period
  • Argentina reports case of monkeypox; man traveled from Spain
  • FDA Okays IN.PACT 018 Drug-Coated Balloon for PAD
Copyright © All rights reserved.